Inmed announces management changes

Vancouver, british columbia, march 17, 2022 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq: inm), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, today announces that its chief financial officer, mr. bruce colwill, will be retiring and will be stepping down from his position at the company effective march 31, 2022. mr. colwill will continue to serve as an advisor through june 30, 2022 to facilitate a smooth transition.
INM Ratings Summary
INM Quant Ranking